ADAR1 Capital Management’s Keros Therapeutics KROS Stock Holding History

ADAR1 Capital Management’s Portfolio KROS Stock Details KROS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$71.9M	Buy
2025 Q1	$15.1M	Buy
2024 Q4	$368K	Sell
2024 Q3	$25.8M	Sell
2024 Q2	$25.1M	Buy
2024 Q1	$22.4M	Sell
2023 Q4	$27.4M	Buy